Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
for Multiple Sclerosis
22 locations incl. Cullman
Sponsor: Sanofi
Sex: All·Age: 18 - 60
Code: NCT07325292·Phase 3·Recruiting·Listed Jan 2026